Durham, NC, United States of America

Matthew W Mitchell

USPTO Granted Patents = 13 


 

Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 93(Granted Patents)


Company Filing History:


Years Active: 2010-2024

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Innovations and Impact of Inventor Matthew W Mitchell in Biological Sample Assessment

Introduction

Matthew W Mitchell, an accomplished inventor based in Durham, NC, has made significant contributions to the field of biological sample analysis. With a remarkable portfolio of 13 patents, his work primarily focuses on developing innovative methods that enhance the quality assessment of biological samples.

Latest Patents

One of Matthew's latest patents addresses the critical process of automated sample quality assessment. This innovative method involves evaluating the quality of biological samples while ensuring their viability for intended analysis. The process includes analyzing a biological sample obtained from a subject, assessing its quality using specific biomarkers, and performing the intended use analysis concurrently. This approach also encompasses evaluating compliance with sample handling protocols and subject adherence, showcasing a comprehensive strategy for maintaining sample integrity.

Career Highlights

Throughout his career, Matthew W Mitchell has been associated with prominent organizations, including Metabolon, Inc. and Massachusetts General Hospital Corporation. His dedication to advancing the field of biological analysis is evident through his innovative solutions aimed at improving sample quality assessment techniques.

Collaborations

Matthew has had the privilege of collaborating with esteemed colleagues such as Kay A Lawton and Michael V Milburn. These partnerships have enabled him to leverage diverse expertise, further enhancing the development and implementation of his patented technologies.

Conclusion

In conclusion, Matthew W Mitchell's work stands out for its ingenuity and relevance in the life sciences industry. His 13 patents, particularly in automated sample quality assessment, reflect his commitment to improving biological sample analysis. As he continues to innovate, the implications of his work are likely to benefit both academic and clinical research settings significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…